Proteins and signalling pathways targeted by dapagliflozin and finerenone: Insights from DAPA-CKD and FIGARO-DKD.
Saved in:
| Title: | Proteins and signalling pathways targeted by dapagliflozin and finerenone: Insights from DAPA-CKD and FIGARO-DKD. |
|---|---|
| Authors: | de la Rambelje MA; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Voors AA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Greasley PJ; Early Discovery and Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Berger M; R&D Pharmaceuticals, Translational Sciences, Bayer AG, Wuppertal, Germany., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Jan; Vol. 28 (1), pp. 750-753. Date of Electronic Publication: 2025 Oct 13. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.70193 |
